Home/Filings/4/0001179110-21-008981
4//SEC Filing

Gelder Mark S. MD 4

Accession 0001179110-21-008981

CIK 0001130598other

Filed

Sep 28, 8:00 PM ET

Accepted

Sep 29, 8:25 AM ET

Size

4.6 KB

Accession

0001179110-21-008981

Insider Transaction Report

Form 4
Period: 2021-09-28
Gelder Mark S. MD
Chief Medical Officer
Transactions
  • Purchase

    Common Stock

    2021-09-28$4.20/sh+2,381$10,0002,381 total

Issuer

Onconova Therapeutics, Inc.

CIK 0001130598

Entity typeother

Related Parties

1
  • filerCIK 0001564390

Filing Metadata

Form type
4
Filed
Sep 28, 8:00 PM ET
Accepted
Sep 29, 8:25 AM ET
Size
4.6 KB